Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival
International Working Group (IWG) and European LeukemiaNet (ELN) response definitions are utilized to evaluate the efficacy of new agents for childhood acute myeloid leukemia (AML) for regulatory purposes. However, these criteria are not consistent with definitions used in pediatric AML trials or wi...
Main Authors: | Lauren Pommert, Todd M. Cooper, Robert B. Gerbing, Lisa Brodersen, Michael Loken, Alan Gamis, Richard Aplenc, Todd A. Alonzo, Edward Anders Kolb |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/3/616 |
Similar Items
-
Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG
by: Mareike Rasche, et al.
Published: (2021-05-01) -
Successful Treatment of Pediatric Acute Myeloid Leukemia Presenting with Hyperbilirubinemia Secondary to Myeloid Sarcoma: A Case Report
by: Hwazen A. Shash, et al.
Published: (2022-11-01) -
Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group
by: Mareike Rasche, et al.
Published: (2021-02-01) -
Epidemiological evaluation and survival of children with acute myeloid leukemia
by: Rahuany Velleda de Morais, et al.
Published: (2021-03-01) -
Acute myeloid leukemia with RAM immunophenotype: a pediatric case with unusual morphologic features
by: Miriam Conces, et al.
Published: (2017-06-01)